[HTML][HTML] Biomarkers of chemotherapy-induced peripheral neuropathy: Current status and future directions
RL Rodwin, NZ Siddiq, BE Ehrlich… - Frontiers in Pain …, 2022 - frontiersin.org
Chemotherapy induced peripheral neuropathy (CIPN) is an often severe and debilitating
complication of multiple chemotherapeutic agents that can affect patients of all ages, across …
complication of multiple chemotherapeutic agents that can affect patients of all ages, across …
Fear of cancer recurrence or progression: what is it and what can we do about it?
CD Bergerot, EJ Philip, PG Bergerot… - American Society of …, 2022 - ascopubs.org
Patients with cancer face a trajectory marked by emotional and physical distress that can be
associated with both diagnosis and treatment. Fear of cancer recurrence or progression has …
associated with both diagnosis and treatment. Fear of cancer recurrence or progression has …
Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma
N Siddiq, C Bergstrom, LD Anderson… - BMJ Case Reports …, 2019 - casereports.bmj.com
Patients with multiple myeloma (MM) are at risk for acquired dysfibrinogenemia resulting in
laboratory abnormalities and/or bleeding complications. We describe a 63-year-old man …
laboratory abnormalities and/or bleeding complications. We describe a 63-year-old man …
Coagulation Testing in Patients Taking Direct Oral Anticoagulants: A Teachable Moment
N Siddiq, S Nagalla, S Choi - JAMA Internal Medicine, 2019 - jamanetwork.com
Story From the Front Lines A 55-year-old man with a history of atrial fibrillation, hypertension,
and type 2 diabetes mellitus presented to the emergency department (ED) with abdominal …
and type 2 diabetes mellitus presented to the emergency department (ED) with abdominal …